文献速递临床试验与 GCP流行病学与生物统计

TAVR麻醉诱导期胶体与晶体液血流动力学比较:CHAIN-T随机对照试验方案

Crystalloid vs colloid for Hemodynamics during Anesthesia INduction in TAVR patients (CHAIN-T): study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2026-07-24

本研究为单中心、前瞻性、随机、双盲、平行对照试验,计划纳入116例择期全身麻醉下TAVR患者,按1:1随机接受5 ml/kg胶体液或晶体液在麻醉诱导前15分钟内输注,主要结局为诱导期平均动脉压变化曲线下面积,旨在评估胶体预扩容能否减少诱导期低血压。

要点

  • TAVR全麻诱导前给予5 ml/kg胶体或晶体液预扩容,比较对诱导期MAP变化AUC的影响。
  • 主要结局为诱导期(至诱导后15分钟)MAP变化AUC,次要结局包括术中血流动力学不稳定发生率等。
  • 研究结果将为优化TAVR患者麻醉诱导期液体预扩容方案提供证据。

核心结论

  • 该试验旨在评估胶体预扩容相比晶体液能否减少TAVR患者麻醉诱导期低血压。

研究设计与样本

  • 单中心、前瞻性、随机、双盲、平行对照试验,在空军军医大学西京医院开展。
  • 计划纳入116例择期全身麻醉下TAVR患者,按1:1随机分为胶体组和晶体组。

关键数值与推荐

  • 干预:麻醉诱导前15分钟内输注5 ml/kg胶体液或晶体液。
  • 主要结局:诱导期(至诱导后15分钟)平均动脉压变化曲线下面积(AUC)。
  • 次要结局:术中血流动力学不稳定发生率、术中血管活性药物使用、术后第1天SOFA评分、术后住院时长、术后ICU入住率、住院期间及术后30天全因死亡率、术后30天肾脏替代治疗发生率。

临床怎么用

  • 若结果阳性,可为TAVR全麻诱导前选择胶体液预扩容以减少诱导期低血压提供依据。

局限性

  • 单中心设计可能限制结果外推性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess whether preload with colloids could reduce hypotension during induction in patients undergoing transcatheter aortic valve replacement (TAVR) compared to crystalloids. METHODS: This study is a single-center, prospective, randomized, double-blind, parallel-controlled trial conducted at Xijing Hospital. A total of 116 patients scheduled for elective TAVR under general anesthesia will be randomly assigned in a 1:1 ratio to either the colloid group or the crystalloid group, receiving either 5 ml/kg of colloid or crystalloid solution before anesthesia induction infused over 15 min. The primary outcome is the area under curve (AUC) of the change in mean arterial pressure (MAP) from baseline during the induction period (until 15 min after induction). Secondary outcomes include the incidence of intraoperative hemodynamic instability, the use of intraoperative vasoactive drugs, the Sequential Organ Failure Assessment (SOFA) score on the first postoperative day, postoperative hospital length of stay, the rate of intensive care unit (ICU) admission postoperatively, all-cause mortality during hospitalization and by 30 days after surgery, and the incidence of renal replacement therapy by 30 days after surgery. DISCUSSION: The results of this study will provide evidence on optimizing fluid preload to prevent hypotension during induction, reduce postoperative complications, and enhance recovery for patients undergoing TAVR. The findings are expected to promote anesthesia protocols in this patient population. TRIAL REGISTRATION: The study protocol and statistical analysis plan were approved by the institutional Ethics Committee of Xijing Hospital, Fourth Military Medical University (XJLL-KY-20252560). The study was registered in ClinicalTrials.gov (NCT07329660) on December 29, 2025.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Tuo X, Wang F, Chen Y, et al. Crystalloid vs colloid for Hemodynamics during Anesthesia INduction in TAVR patients (CHAIN-T): study protocol for a randomized controlled trial. Trials. 2026. PMID: 42902397. doi:10.1186/s13063-026-09906-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。